People Are “Micro-dosing” Their Weight-Loss Drugs — Best Life
When the new class of drugs—including Ozempic, Wegovy, Zepbound, and Mounjaro—gained FDA approval in 2023 to help patients manage diabetes and lose weight, it was already considered relatively uncharted territory within the medical world. Now, […]